SCHEMBL4593546

SCHEMBL4593546

O=S(=O)(c1ccc(O)cc1)c1ccc(O)c2ccccc12

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LDHA P00338 1/20 0.59
POLB P06746 2/20 0.54
GAA P10253 2/20 0.54
GFER P55789 1/20 0.54
ALPL P05186 1/20 0.53
ALPI P09923 1/20 0.53
ALPG P10696 1/20 0.53
DNMT1 P26358 1/20 0.53
MCL1 Q07820 1/20 0.53
TDP1 Q9NUW8 1/20 0.53
L3MBTL1 Q9Y468 1/20 0.53
HKDC1 Q2TB90 1/20 0.50
COMT P21964 2/20 0.49
IDO1 P14902 1/20 0.46
HTR6 P50406 1/20 0.46
CDK2 P24941 1/20 0.46
CA12 O43570 1/20 0.44
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44
CA9 Q16790 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10693393 0.89 LDHA (0.63) LDHAPOLBGAAGFERALPL
SCHEMBL7085229 0.85 LDHA (0.73) LDHAALPLALPIALPGDNMT1
SCHEMBL7545258 0.83 LDHA (0.53) LDHAPOLBGAAGFERHKDC1
SCHEMBL7198914 0.83 LDHA (0.53) LDHAPOLBGAAGFERALPL
Formaldehyde SCHEMBL15348636 0.83 HKDC1 (0.50) LDHAPOLBGAAGFERALPL
SCHEMBL8510632 0.83 RAPGEF4 (0.47) POLBGAAGFERALPLALPI
SCHEMBL8509341 0.83 POLB (0.45) POLBGAAGFERALPLALPI
SCHEMBL14030697 0.82 GAA (0.60) LDHAPOLBGAAGFERL3MBTL1
SCHEMBL7184588 0.80 GAA (0.41) LDHAPOLBGAAGFERALPL
SCHEMBL8509876 0.79 GAA (0.50) GAAL3MBTL1HTR6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080255232-A1 Naphthyl Derivatives as Inhibitors of Beta-Amyloid Aggregation SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) 2008-10-16 US claimed
EP-1937243-A2 NAPHTHYL DERIVATIVES AS INHIBITORS OF BETA-AMYLOID AGGREGATION SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. (IT) 2008-07-02 EP claimed
WO-2007045593-A2 NAPHTHYL DERIVATIVES AS INHIBITORS OF BETA-AMYLOID AGGREGATION SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) 2007-04-26 WO claimed
US-4996279-A Crosslinked epoxies from diepoxides, diphenols, primary and secondary amines with stiff and flexible units; melt processability SHELL OIL COMPANY (US) 1991-02-26 US claimed
CN-101291665-A Naphthyl derivatives as inhibitors of beta-amyloid aggregation SIGMA TAU IND FARMACEUTI (IT) 2008-10-22 CN disclosed
US-20080255232-A1 Naphthyl Derivatives as Inhibitors of Beta-Amyloid Aggregation SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) 2008-10-16 US disclosed
US-20080255232-A1 Naphthyl Derivatives as Inhibitors of Beta-Amyloid Aggregation SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) 2008-10-16 US disclosed
US-20080255232-A1 Naphthyl Derivatives as Inhibitors of Beta-Amyloid Aggregation SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) 2008-10-16 US disclosed
EP-1937243-A2 NAPHTHYL DERIVATIVES AS INHIBITORS OF BETA-AMYLOID AGGREGATION SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. (IT) 2008-07-02 EP disclosed
WO-2007045593-A2 NAPHTHYL DERIVATIVES AS INHIBITORS OF BETA-AMYLOID AGGREGATION SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) 2007-04-26 WO disclosed
WO-2007045593-A2 NAPHTHYL DERIVATIVES AS INHIBITORS OF BETA-AMYLOID AGGREGATION SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) 2007-04-26 WO disclosed
EP-1304924-A2 COMPOSITIONS FOR REPELLING CRAWLING INSECTS Bayer Aktiengesellschaft (DE) 2003-05-02 EP disclosed
EP-0608579-A1 A heat and light sensitive imaging element AGFA-GEVAERT N.V. (BE) 1994-08-03 EP disclosed
EP-0599368-A1 Thermal imaging method AGFA-GEVAERT N.V. (BE) 1994-06-01 EP disclosed
EP-0582753-A1 Heat- and photosensitive imaging element AGFA-GEVAERT N.V. (BE) 1994-02-16 EP disclosed
EP-0252691-B1 HEAT-SENSITIVE RECORD MATERIAL KANZAKI PAPER MANUFACTURING COMPANY LIMITED (JP) 1991-09-18 EP disclosed
US-4996279-A Crosslinked epoxies from diepoxides, diphenols, primary and secondary amines with stiff and flexible units; melt processability SHELL OIL COMPANY (US) 1991-02-26 US disclosed
US-4960912-A EPOXY RESINS, POLYEPOXDIES SHELL OIL COMPANY (US) 1990-10-02 US disclosed
US-4771033-A CHROMOGEN, PHENOL COMPOUND, ACIDIC ACCEPTOR ON A BASE SHEET KANZAKI PAPER MANUFACTURING CO., LTD. (JP) 1988-09-13 US disclosed
EP-0252691-A2 Heat-sensitive record material KANZAKI PAPER MANUFACTURING COMPANY LIMITED (JP) 1988-01-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080255232-A1 Naphthyl Derivatives as Inhibitors of Beta-Amyloid Aggregation APP, BACE1, SNCA LDHA 2001/4885POLB 1245/4885GAA 38/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.